Nutex Health (NUTX) Non-Current Deferred Tax Liability (2021 - 2025)
Nutex Health's Non-Current Deferred Tax Liability history spans 5 years, with the latest figure at $15.0 million for Q3 2025.
- For Q3 2025, Non-Current Deferred Tax Liability rose 339.47% year-over-year to $15.0 million; the TTM value through Sep 2025 reached $15.0 million, up 339.47%, while the annual FY2023 figure was $5.1 million, 50.77% down from the prior year.
- Non-Current Deferred Tax Liability for Q3 2025 was $15.0 million at Nutex Health, up from $3.4 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $17.5 million in Q2 2022 and bottomed at $1.7 million in Q1 2022.
- The 5-year median for Non-Current Deferred Tax Liability is $5.1 million (2023), against an average of $6.9 million.
- The largest annual shift saw Non-Current Deferred Tax Liability soared 619.07% in 2022 before it crashed 67.87% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.4 million in 2021, then soared by 330.22% to $10.5 million in 2022, then tumbled by 50.77% to $5.1 million in 2023, then crashed by 33.87% to $3.4 million in 2024, then surged by 339.47% to $15.0 million in 2025.
- Per Business Quant, the three most recent readings for NUTX's Non-Current Deferred Tax Liability are $15.0 million (Q3 2025), $3.4 million (Q3 2024), and $2.8 million (Q2 2024).